Cargando…
Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
BACKGROUND: Gonadotropin-releasing hormone receptor (GnRHR) is expressed in several malignant tumors and inhibits the proliferation and metastasis of cancer cells, but its role in triple-negative breast cancers (TNBCs) is unclear. This study investigated the biological effects of GnRHR and their inf...
Autores principales: | Chen, Cai-Ping, Lu, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918972/ https://www.ncbi.nlm.nih.gov/pubmed/35264044 http://dx.doi.org/10.1177/03000605221082895 |
Ejemplares similares
-
The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
por: Gründker, Carsten, et al.
Publicado: (2017) -
Application of luteinizing hormone-releasing hormone–ferrosoferric oxide nanoparticles in targeted imaging of breast tumors
por: Nian, Di, et al.
Publicado: (2019) -
Cytoskeletal and extracellular matrix proteins as markers for metastatic triple negative breast cancer
por: Mohammed, Mohammed Elimam Ahamed, et al.
Publicado: (2019) -
Microarray data reveal potential genes that regulate triple-negative
breast cancer
por: Pan, Chi, et al.
Publicado: (2022) -
Gonadotropin-releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells
por: TENG, LOONG HUNG, et al.
Publicado: (2015)